A team of scientists from France has recently demonstrated the efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma therapy in improving the survival rate among patients with B-cell ...

Insight into the clinical potential of convalescent plasma in patients with coronavirus disease (COVID-19) is important given the severe clinical courses in unvaccinated and seronegative individuals.

When people recover from viral diseases, they make antibodies that can then be transferred to other affected individuals.

The FDA’s withdrawal of its authorization for Evusheld, a monoclonal antibody therapy used to prevent and treat Covid-19, leaves no monoclonals available for this purpose. Another monoclonal, ...

Six months after it was controversially hailed by Trump administration officials as a “breakthrough” therapy to fight the worst effects of Covid-19, convalescent plasma appears to be on the ropes.

Convalescent plasma therapy has shown a weak benefit in patients with severe or life-threatening Covid-19. However, when considering safety, 1 some have advocated its use beyond this limited scope.

After I was diagnosed with covid-19 almost a year back, I enrolled in a covid-19-positive plasma donation program. Its goal was to study whether plasma from donors who had recovered from covid-19 ...

Plasma donation is a specific form of blood donation whereby plasma, the clear liquid component of whole blood, is collected during donation through a process known as plasmapheresis. During ...